Atacicept in Multiple Glomerular Diseases

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

NCT05834738 ·Status: COMPLETED ·Phase: PHASE2

Study of Telitacicept in Patients With Refractory IgA Nephropathy

NCT05596708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

NCT03019653 ·Status: COMPLETED ·Phase: PHASE1

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

NCT03373461 ·Status: COMPLETED ·Phase: PHASE2

Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

NCT00396721 ·Status: COMPLETED ·Phase: PHASE2

Acthar on Proteinuria in IgA Nephropathy Patients

NCT02382523 ·Status: WITHDRAWN ·Phase: PHASE4

A Study of Telitacicept for IgA Nephropathy (TELIGAN)

NCT05799287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

NCT04456816 ·Status: RECRUITING ·Phase: PHASE2

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

NCT01386554 ·Status: COMPLETED ·Phase: PHASE4

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

NCT05546047 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)

NCT05125068 ·Status: TERMINATED ·Phase: PHASE2

Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

NCT07056595 ·Status: RECRUITING ·Phase: NA

An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis

NCT06664814 ·Status: RECRUITING ·Phase: PHASE2

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

NCT05517980 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

NCT07219121 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

NCT06564142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria

NCT02633046 ·Status: COMPLETED ·Phase: PHASE4

Comparing the Performance of Serum Creatinine and Cystatin C-based GFR Estimations in Predicting Directly Measured GFR in Patients With or Without Nephrotic Syndrome

NCT06797609 ·Status: ACTIVE_NOT_RECRUITING

Effect of Finerenone in IgA Nephropathy

NCT06580288 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy

NCT04080076 ·Status: WITHDRAWN ·Phase: PHASE4

Atrasentan in Patients With IgA Nephropathy

NCT04573478 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

NCT05696613 ·Status: RECRUITING ·Phase: PHASE3

A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)

NCT01665391 ·Status: COMPLETED ·Phase: PHASE2

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

NCT06676384 ·Status: RECRUITING ·Phase: PHASE4

A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

NCT01763580 ·Status: COMPLETED ·Phase: PHASE4